IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $844,000 | +30.7% | 22,794 | +58.7% | 0.07% | +56.5% |
| Q1 2021 | $646,000 | -23.5% | 14,360 | -19.3% | 0.05% | -68.3% |
| Q3 2020 | $844,000 | +137.1% | 17,795 | +194.4% | 0.14% | +253.7% |
| Q2 2020 | $356,000 | +1.7% | 6,044 | +11.1% | 0.04% | +95.2% |
| Q2 2019 | $350,000 | -52.3% | 5,439 | -39.8% | 0.02% | -50.0% |
| Q1 2019 | $734,000 | +10.0% | 9,041 | -40.3% | 0.04% | +16.7% |
| Q1 2018 | $667,000 | +77.4% | 15,132 | +102.4% | 0.04% | +80.0% |
| Q4 2017 | $376,000 | -70.1% | 7,476 | -69.8% | 0.02% | -67.7% |
| Q3 2017 | $1,257,000 | +513.2% | 24,789 | +648.0% | 0.06% | +113.8% |
| Q4 2015 | $205,000 | – | 3,314 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |